MANKIND vs TORNTPHARM — stock comparison
Mankind Pharma Ltd (MANKIND) vs Torrent Pharmaceuticals Ltd (TORNTPHARM): price, valuation, ROE, margins and Traddx's fundamentals grade, side by side. Live NSE/BSE data.
On Traddx's fundamentals score, MANKIND grades higher (B+ 72 vs B 66). Not investment advice.
1-year price performance — higher line = stronger return
■ MANKIND +1.8%■ TORNTPHARM +36.5%Past year, both rebased to 100
| MANKIND | TORNTPHARM | |
|---|---|---|
| Traddx grade | B+ (72) | B (66) |
| Price | ₹2,485.20 | ₹4,778.00 |
| Today | 0.21% | 0.48% |
| P/E | 48.40 | 81.60 |
| ROE | 13.10% | 27.40% |
| Net margin | 18.84% | 11.83% |
| Debt / equity | 0.39 | 1.79 |
| 52-week high | ₹2,640.30 | ₹5,249.95 |
| 52-week low | ₹1,909.90 | ₹3,480.00 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open MANKIND live → Open TORNTPHARM live →